BriaCell Therapeutics

$3.28
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.02 (+0.62%) Today
+$0.02 (+0.61%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell BCTX and other stocks, options, and ETFs commission-free!

About BCTX

BriaCell Therapeutics Corp. operates as a clinical-stage biotechnology company that specializes in immunotherapy for advanced breast cancer. It is advancing its targeted immunotherapy program by conducting a Phase I/IIA clinical trial with Bria-IMT in combination with an immune checkpoint inhibitor and a companion diagnostic test, BriaDx, to identify patients to benefit from Bria-IMT.

CEO
William V. Williams
Employees
—
Headquarters
West Vancouver, British Columbia
Founded
2006
Market Cap
20.97M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
3.30M
High Today
$3.31
Low Today
$3.11
Open Price
$3.24
Volume
558.69K
52 Week High
$9.22
52 Week Low
$2.89

BCTX Earnings

Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected Jun 15, Pre-Market

You May Also Like

SCE-G
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure